Li W - Search Results

1

[Advances of Treatment of Pulmonary Large Cell Neuroendocrine Carcinoma].

Sun J, Jing Y, Tian P, Li W, Li Y. Sun J, et al. Among authors: li y, li w. Zhongguo Fei Ai Za Zhi. 2024 Aug 20;27(8):622-628. doi: 10.3779/j.issn.1009-3419.2024.102.28. Zhongguo Fei Ai Za Zhi. 2024. PMID: 39318255 Free PMC article. Review. Chinese.

2

[Progress in the application of medical thoracoscopic pleural biopsy].

Wang KG, Li WM, Tian PW, Liu D. Wang KG, et al. Among authors: li wm. Zhonghua Jie He He Hu Xi Za Zhi. 2020 Jul 12;43(7):592-594. doi: 10.3760/cma.j.cn112147-20190903-00614. Zhonghua Jie He He Hu Xi Za Zhi. 2020. PMID: 32629561 Review. Chinese.

3

Persistent increase and improved survival of stage I lung cancer based on a large-scale real-world sample of 26,226 cases.

Wang C, Shao J, Song L, Ren P, Liu D, Li W. Wang C, et al. Among authors: li w. Chin Med J (Engl). 2023 Aug 20;136(16):1937-1948. doi: 10.1097/CM9.0000000000002729. Epub 2023 Jun 30. Chin Med J (Engl). 2023. PMID: 37394562 Free PMC article.

4

Association between pretreatment C-reactive protein level and survival in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis.

Wang H, Yang R, Zhou K, Wang S, Cheng C, Liu D, Li W. Wang H, et al. Among authors: li w. Int Immunopharmacol. 2023 Nov;124(Pt B):110937. doi: 10.1016/j.intimp.2023.110937. Epub 2023 Sep 25. Int Immunopharmacol. 2023. PMID: 37757636

5

Prognostic Value of the Glasgow Prognostic Score in Non-Small Cell Lung Cancer Patients Receiving Immunotherapy: A Meta-Analysis.

Wang H, Yang R, Cheng C, Wang S, Liu D, Li W. Wang H, et al. Among authors: li w. Nutr Cancer. 2024;76(2):187-195. doi: 10.1080/01635581.2023.2294522. Epub 2024 Jan 18. Nutr Cancer. 2024. PMID: 38140926

6

[Progress on Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer].

Qi C, Tian P, Li W. Qi C, et al. Among authors: li w. Zhongguo Fei Ai Za Zhi. 2024 Feb 20;27(2):138-146. doi: 10.3779/j.issn.1009-3419.2024.102.06. Zhongguo Fei Ai Za Zhi. 2024. PMID: 38453446 Free PMC article. Review. Chinese.

7

Insights on the ERS/ESTS statement on the management of pleural infection in adults.

Li Y, Zeng H, Tian P, Li W. Li Y, et al. Among authors: li w. Eur Respir J. 2024 Mar 14;63(3):2400008. doi: 10.1183/13993003.00008-2024. Print 2024 Mar. Eur Respir J. 2024. PMID: 38485181 No abstract available.

8

Immune checkpoint inhibitor plus chemotherapy as first-line treatment for non-small cell lung cancer with malignant pleural effusion: a retrospective multicenter study.

Wei Q, Deng T, Wu J, Zeng H, Qi C, Tan S, Zhang Y, Huang Q, Pu X, Xu W, Li W, Tian P, Li Y. Wei Q, et al. Among authors: li y, li w. BMC Cancer. 2024 Mar 28;24(1):393. doi: 10.1186/s12885-024-12173-1. BMC Cancer. 2024. PMID: 38549044 Free PMC article.

9

The real-world treatment characteristic and efficacy of immune checkpoint inhibitors in non-small cell lung cancer: Data from a retrospective cohort study.

Zhang C, Shao J, Tang X, Wu J, Li P, Li W, Wang C. Zhang C, et al. Among authors: li w, li p. Int Immunopharmacol. 2024 Jun 15;134:112152. doi: 10.1016/j.intimp.2024.112152. Epub 2024 May 17. Int Immunopharmacol. 2024. PMID: 38761777 Free article.

10

The combination of tumor mutational burden and T-cell receptor repertoire predicts the response to immunotherapy in patients with advanced non-small cell lung cancer.

Li Y, Ji L, Zhang Y, Zhang J, Reuben A, Zeng H, Huang Q, Wei Q, Tan S, Xia X, Li W, Zhang J, Tian P. Li Y, et al. Among authors: li w. MedComm (2020). 2024 Jun 5;5(6):e604. doi: 10.1002/mco2.604. eCollection 2024 Jun. MedComm (2020). 2024. PMID: 38840771 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82,580 results

Search Page

Filters